StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
RFLRafael Holdings, Inc.
stockpulse.co.kr
NYSE
$1.31▲ 2.34%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $68.1MShares out 52.0M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

8
  • 9.30Pre-market26.09.30 20:23
    8-KKey event#●●●#●●●

    Rafael Holdings, Inc.

    Rafael Holdings announced topline results from the Phase 3 TransportNPC study of Trappsol Cyclo, which did not achieve statistical significance on the primary endpoint but showed a significant treatment effect in a prespecified subgroup. The company remains on track to submit an NDA to the FDA in the fourth quarter of 2026.…more

    $1.31+2.34%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.23Regular26.09.24 03:36
    4Ownership

    Rafael Holdings, Inc.

    Insider David Polinsky of Rafael Holdings, Inc. reported a change in beneficial ownership of securities effective September 21, 2026. This filing is a standard Form 4 disclosure regarding insider stock transactions.…more

    $1.31+2.34%vs prev close
    View filingShare
  • 7.31After-hours26.08.01 05:54
    4Ownership

    Rafael Holdings, Inc.

    Rafael Holdings, Inc.의 내부자 하워드 S. 조나스(Howard S. Jonas)가 2026년 7월 29일 자로 주식 소유 현황 변동을 보고하는 Form 4를 제출했습니다. 본 공시는 해당 임원의 지분 변동 내역을 공식화하는 절차입니다.…more

    $1.31+2.34%vs prev close
    View filingShare

7 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 9.30Regular26.10.01 02:39
    Bullish#●●●#●●●

    Rafael Holdings Shares Plunge After Phase 3 Trial Misses Primary Endpoint…more

    Rafael Holdings' subsidiary, Cyclo Therapeutics, failed to meet the primary endpoint in its Phase 3 trial for a Niemann-Pick disease treatment. Despite some positive results in a subgroup analysis, the stock dropped significantly following the news.…more

    $1.31+2.34%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 9.30Pre-market26.09.30 20:00

    ●●●●●●●● ●●●●● ●●●●●●

    Rafael Holdings' Phase 3 study for its NPC treatment failed to meet the primary endpoint for statistical significance, though a prespecified subgroup analysis showed meaningful clinical benefits. The company remains on track to submit an NDA to the FDA in the fourth quarter of 2026.…more

    $1.31+2.34%vs prev close
    Read sourceShareGlobeNewswire

1 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →